APA
Tamminga C., Sedegah M., Regis D., Chuang I., Epstein J. E., Spring M., Mendoza-Silveiras J., McGrath S., Maiolatesi S., Reyes S., Steinbeiss V., Fedders C., Smith K., House B., Ganeshan H., Lejano J., Abot E., Banania G. J., Sayo R., Farooq F., Belmonte M., Murphy J., Komisar J., Williams J., Shi M., Brambilla D., Manohar N., Richie N. O., Wood C., Limbach K., Patterson N. B., Bruder J. T., Doolan D. L., King C. R., Diggs C., Soisson L., Carucci D., Levine G., Dutta S., Hollingdale M. R., Ockenhouse C. F. & Richie T. L. (20120202). Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. : PloS one.
Chicago
Tamminga Cindy, Sedegah Martha, Regis David, Chuang Ilin, Epstein Judith E, Spring Michele, Mendoza-Silveiras Jose, McGrath Shannon, Maiolatesi Santina, Reyes Sharina, Steinbeiss Victoria, Fedders Charlotte, Smith Kathryn, House Brent, Ganeshan Harini, Lejano Jennylynn, Abot Esteban, Banania Glenna J, Sayo Renato, Farooq Fouzia, Belmonte Maria, Murphy Jittawadee, Komisar Jack, Williams Jackie, Shi Meng, Brambilla Donald, Manohar Nalini, Richie Nancy O, Wood Chloe, Limbach Keith, Patterson Noelle B, Bruder Joseph T, Doolan Denise L, King C Richter, Diggs Carter, Soisson Lorraine, Carucci Daniel, Levine Gail, Dutta Sheetij, Hollingdale Michael R, Ockenhouse Christian F and Richie Thomas L. 20120202. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. : PloS one.
Harvard
Tamminga C., Sedegah M., Regis D., Chuang I., Epstein J. E., Spring M., Mendoza-Silveiras J., McGrath S., Maiolatesi S., Reyes S., Steinbeiss V., Fedders C., Smith K., House B., Ganeshan H., Lejano J., Abot E., Banania G. J., Sayo R., Farooq F., Belmonte M., Murphy J., Komisar J., Williams J., Shi M., Brambilla D., Manohar N., Richie N. O., Wood C., Limbach K., Patterson N. B., Bruder J. T., Doolan D. L., King C. R., Diggs C., Soisson L., Carucci D., Levine G., Dutta S., Hollingdale M. R., Ockenhouse C. F. and Richie T. L. (20120202). Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. : PloS one.
MLA
Tamminga Cindy, Sedegah Martha, Regis David, Chuang Ilin, Epstein Judith E, Spring Michele, Mendoza-Silveiras Jose, McGrath Shannon, Maiolatesi Santina, Reyes Sharina, Steinbeiss Victoria, Fedders Charlotte, Smith Kathryn, House Brent, Ganeshan Harini, Lejano Jennylynn, Abot Esteban, Banania Glenna J, Sayo Renato, Farooq Fouzia, Belmonte Maria, Murphy Jittawadee, Komisar Jack, Williams Jackie, Shi Meng, Brambilla Donald, Manohar Nalini, Richie Nancy O, Wood Chloe, Limbach Keith, Patterson Noelle B, Bruder Joseph T, Doolan Denise L, King C Richter, Diggs Carter, Soisson Lorraine, Carucci Daniel, Levine Gail, Dutta Sheetij, Hollingdale Michael R, Ockenhouse Christian F and Richie Thomas L. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. : PloS one. 20120202.